{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T21:17:52Z","timestamp":1785705472958,"version":"3.56.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Gaziantep Islam Science and Technology University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Juvenile Idiopathic Arthritis (JIA) can affect ocular structures, but choroidal involvement is not well understood. This study investigates the Choroidal Vascularity Index (CVI) in JIA patients compared to healthy controls and explores its relationship with disease activity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this cross-sectional study, 35 JIA patients and 40 healthy controls underwent comprehensive ophthalmic examination and swept-source optical coherence tomography (SS-OCT). CVI, central macular thickness (CMT), and subfoveal choroidal thickness (SFCT) were measured. The Juvenile Arthritis Disease Activity Score (JADAS) was calculated for JIA patients. Statistical analysis included comparison between groups and correlation analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>JIA patients showed significantly lower CVI compared to controls (68.3\u2009\u00b1\u20092.5% vs. 72\u2009\u00b1\u20094.6%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). No significant difference was found in SFCT. CVI demonstrated a moderate negative correlation with JADAS (r\u2009=\u2009-0.368, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). However, receiver operating characteristic (ROC) analysis revealed poor diagnostic performance of CVI for detecting JIA (AUC\u2009=\u20090.25).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The study reveals reduced choroidal vascularity in JIA patients and a correlation between CVI and disease activity. While CVI shows limited diagnostic utility, it may serve as a potential marker for monitoring inflammatory burden and treatment response in JIA. Further research is needed to establish its clinical utility fully.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00417-025-06759-z","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T23:22:26Z","timestamp":1738365746000},"page":"1693-1700","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Assessment of choroidal vascularity index in juvenile idiopathic arthritis: implications for disease monitoring"],"prefix":"10.1007","volume":"263","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1154-425X","authenticated-orcid":false,"given":"\u0130brahim Edhem","family":"Y\u0131lmaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6314-9246","authenticated-orcid":false,"given":"Gizem G\u00fcrbostan","family":"Soysal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5430-8359","authenticated-orcid":false,"given":"Veysel","family":"Do\u011fru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0492-5767","authenticated-orcid":false,"given":"Sevim Ayca","family":"Seyyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,1]]},"reference":[{"key":"6759_CR1","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S0140-6736(07)60363-8","volume":"369","author":"A Ravelli","year":"2007","unstructured":"Ravelli A, Martini A (2007) Juvenile idiopathic arthritis. Lancet 369:767\u2013778. https:\/\/doi.org\/10.1016\/S0140-6736(07)60363-8","journal-title":"Lancet"},{"key":"6759_CR2","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/S0140-6736(11)60244-4","volume":"377","author":"B Prakken","year":"2011","unstructured":"Prakken B, Albani S, Martini A (2011) Juvenile idiopathic arthritis. The Lancet 377:2138\u20132149. https:\/\/doi.org\/10.1016\/S0140-6736(11)60244-4","journal-title":"The Lancet"},{"key":"6759_CR3","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/NRRHEUM.2009.209","volume":"5","author":"C Macaubas","year":"2009","unstructured":"Macaubas C, Nguyen K, Milojevic D et al (2009) Oligoarticular and polyarticular JIA: epidemiology and pathogenesis. Nat Rev Rheumatol 5:616\u2013626. https:\/\/doi.org\/10.1038\/NRRHEUM.2009.209","journal-title":"Nat Rev Rheumatol"},{"key":"6759_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12969-016-0088-2","volume":"14","author":"SL Clarke","year":"2016","unstructured":"Clarke SL, Sen ES, Ramanan AV (2016) Juvenile idiopathic arthritis-associated uveitis. Pediatric. Rheumatology 14:1\u20131. https:\/\/doi.org\/10.1186\/S12969-016-0088-2","journal-title":"Rheumatology"},{"key":"6759_CR5","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3109\/09273948.2013.791701","volume":"21","author":"A Heiligenhaus","year":"2013","unstructured":"Heiligenhaus A, Heinz C, Edelsten C et al (2013) Review for disease of the year: epidemiology of juvenile idiopathic arthritis and its associated uveitis: the probable risk factors. Ocul Immunol Inflamm 21:180\u2013191. https:\/\/doi.org\/10.3109\/09273948.2013.791701","journal-title":"Ocul Immunol Inflamm"},{"key":"6759_CR6","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P et al (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390\u2013392","journal-title":"J Rheumatol"},{"key":"6759_CR7","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/ACR.23871","volume":"71","author":"ST Angeles-Han","year":"2019","unstructured":"Angeles-Han ST, Ringold S, Beukelman T et al (2019) 2019 American College of Rheumatology\/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis. Arthritis Care Res (Hoboken) 71:703\u2013716. https:\/\/doi.org\/10.1002\/ACR.23871","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"6759_CR8","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1002\/ART.34343","volume":"64","author":"CA Wallace","year":"2012","unstructured":"Wallace CA, Giannini EH, Spalding SJ et al (2012) Trial of Early Aggressive Therapy in Polyarticular Juvenile Idiopathic Arthritis. Arthritis Rheum 64:2012. https:\/\/doi.org\/10.1002\/ART.34343","journal-title":"Arthritis Rheum"},{"key":"6759_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1546-0096-12-13","volume":"12","author":"ML Stoll","year":"2014","unstructured":"Stoll ML, Cron RQ (2014) Treatment of juvenile idiopathic arthritis: a revolution in care. Pediatr Rheumatol Online J 12:13. https:\/\/doi.org\/10.1186\/1546-0096-12-13","journal-title":"Pediatr Rheumatol Online J"},{"key":"6759_CR10","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/J.PRETEYERES.2009.12.002","volume":"29","author":"DL Nickla","year":"2010","unstructured":"Nickla DL, Wallman J (2010) The multifunctional choroid. Prog Retin Eye Res 29:144\u2013168. https:\/\/doi.org\/10.1016\/J.PRETEYERES.2009.12.002","journal-title":"Prog Retin Eye Res"},{"key":"6759_CR11","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/J.AJO.2008.05.032","volume":"146","author":"RF Spaide","year":"2008","unstructured":"Spaide RF, Koizumi H, Pozonni MC (2008) Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol 146:496\u2013500. https:\/\/doi.org\/10.1016\/J.AJO.2008.05.032","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"6759_CR12","doi-asserted-by":"publisher","first-page":"e0146344","DOI":"10.1371\/JOURNAL.PONE.0146344","volume":"11","author":"R Agrawal","year":"2016","unstructured":"Agrawal R, Salman M, Tan KA, Karampelas M, Sim DA, Keane PA, Pavesio C (2016) Choroidal vascularity index (CVI)-a novel optical coherence tomography parameter for monitoring patients with panuveitis? PLoS One. 11(1):e0146344. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0146344","journal-title":"PLoS One."},{"key":"6759_CR13","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1097\/IAE.0000000000001312","volume":"37","author":"X Wei","year":"2017","unstructured":"Wei X, Ting DSW, Ng WY et al (2017) CHOROIDAL VASCULARITY INDEX: A Novel Optical Coherence Tomography Based Parameter in Patients With Exudative Age-Related Macular Degeneration. Retina 37:1120\u20131125. https:\/\/doi.org\/10.1097\/IAE.0000000000001312","journal-title":"Retina"},{"key":"6759_CR14","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/S00296-021-05023-X\/METRICS","volume":"42","author":"A A\u011f\u0131n","year":"2022","unstructured":"A\u011f\u0131n A, Kaday\u0131f\u00e7\u0131lar S, Baytaro\u011flu A et al (2022) Assessment of systemic and ocular inflammation in juvenile idiopathic arthritis via choroidal vascularity index. Rheumatol Int 42:1187\u20131196. https:\/\/doi.org\/10.1007\/S00296-021-05023-X\/METRICS","journal-title":"Rheumatol Int"},{"issue":"1","key":"6759_CR15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41598-017-18511-7","volume":"8","author":"M Kim","year":"2018","unstructured":"Kim M, Ha MJ, Choi SY, Park YH (2018) Choroidal vascularity index in type-2 diabetes analyzed by swept-source optical coherence tomography. Scientif Rep 8(1):70. https:\/\/doi.org\/10.1038\/s41598-017-18511-7","journal-title":"Scientif Rep"},{"key":"6759_CR16","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1007\/S10792-019-01080-1","volume":"39","author":"S Emre","year":"2019","unstructured":"Emre S, G\u00fcven-Y\u0131lmaz S, Ulusoy MO, Ate\u015f H (2019) Optical coherence tomography angiography findings in Behcet patients. Int Ophthalmol 39:2391\u20132399. https:\/\/doi.org\/10.1007\/S10792-019-01080-1","journal-title":"Int Ophthalmol"},{"key":"6759_CR17","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/ART.24516","volume":"61","author":"A Consolaro","year":"2009","unstructured":"Consolaro A, Ruperto N, Bazso A et al (2009) Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum 61:658\u2013666. https:\/\/doi.org\/10.1002\/ART.24516","journal-title":"Arthritis Rheum"},{"key":"6759_CR18","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/S10384-024-01074-2","volume":"68","author":"B Y\u0131lmaz Tu\u011fan","year":"2024","unstructured":"Y\u0131lmaz Tu\u011fan B, S\u00f6nmez HE, \u015eahin N et al (2024) Retinal vessel density and choroidal flow changes in oligoarticular juvenile idiopathic arthritis with and without uveitis. Jpn J Ophthalmol 68:327\u2013337. https:\/\/doi.org\/10.1007\/S10384-024-01074-2","journal-title":"Jpn J Ophthalmol"},{"key":"6759_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12348-017-0136-1","volume":"7","author":"P Dutta Majumder","year":"2017","unstructured":"Dutta Majumder P, Ghose A, Rao C, Bhende M, Biswas J (2017) A case of choroidal neovascular membrane in 6-year-old boy with juvenile idiopathic arthritis. J Ophthal Inflamm Infect 7:1\u20133. https:\/\/doi.org\/10.1186\/S12348-017-0136-1","journal-title":"J Ophthal Inflamm Infect"},{"key":"6759_CR20","unstructured":"(PDF) Role of Cytokine in Pathogenesis of Juvenile Idiopathic Arthritis. https:\/\/www.researchgate.net\/publication\/328392016_Role_of_Cytokine_in_Pathogenesis_of_Juvenile_Idiopathic_Arthritis. Accessed 6 Oct 2024"},{"key":"6759_CR21","doi-asserted-by":"publisher","first-page":"6171","DOI":"10.1167\/iovs.12-10026","volume":"53","author":"K Balaskas","year":"2012","unstructured":"Balaskas K, Ballabeni P, Guex-Crosier Y (2012) Retinal Thickening in HLA-B27\u2013Associated Acute Anterior Uveitis: Evolution with Time and Association with Severity of Inflammatory Activity. Investig Opthalmol Vis Sci 53:6171. https:\/\/doi.org\/10.1167\/iovs.12-10026","journal-title":"Investig Opthalmol Vis Sci"},{"key":"6759_CR22","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2024.2381639","author":"M Berhuni","year":"2024","unstructured":"Berhuni M, Albayrak F, G\u00f6l M (2024) Choroidal Vascularity Index and Subfoveal Choroidal Thickness in Rheumatoid Arthritis Assessed with Enhanced-Depth Imaging Optical Coherence Tomography. Ocul Immunol Inflamm. https:\/\/doi.org\/10.1080\/09273948.2024.2381639","journal-title":"Ocul Immunol Inflamm"},{"key":"6759_CR23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/ICU.0000000000000559","volume":"30","author":"J Gueudry","year":"2019","unstructured":"Gueudry J, Touhami S, Quartier P, Bodaghi B (2019) Therapeutic advances in juvenile idiopathic arthritis - associated uveitis. Curr Opin Ophthalmol 30:179\u2013186. https:\/\/doi.org\/10.1097\/ICU.0000000000000559","journal-title":"Curr Opin Ophthalmol"},{"key":"6759_CR24","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.2147\/OPTH.S23646","volume":"5","author":"K Kotaniemi","year":"2011","unstructured":"Kotaniemi K, S\u00e4il\u00e4 H, Kautiainen H (2011) Long-term efficacy of adalimumab in the treatment of uveitis associated with juvenile idiopathic arthritis. Clin Ophthalmol 5:1425\u20131429. https:\/\/doi.org\/10.2147\/OPTH.S23646","journal-title":"Clin Ophthalmol"},{"key":"6759_CR25","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/ACR.23610","volume":"71","author":"ST Angeles-Han","year":"2019","unstructured":"Angeles-Han ST, Lo MS, Henderson LA et al (2019) Childhood arthritis and rheumatology research alliance consensus treatment plans for juvenile idiopathic arthritis\u2013Associated and idiopathic chronic anterior uveitis. Arthritis Care Res (Hoboken) 71:482\u2013491. https:\/\/doi.org\/10.1002\/ACR.23610","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"6759_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1745-6215-15-14","volume":"15","author":"AV Ramanan","year":"2014","unstructured":"Ramanan AV, Dick AD, Benton D, Compeyrot-Lacassagne S, Dawoud D, Hardwick B, Hickey H, Hughes D, Jones A, Woo P, Edelsten C (2014) A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial). Trials 15:1\u20133. https:\/\/doi.org\/10.1186\/1745-6215-15-14","journal-title":"Trials"},{"key":"6759_CR27","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.2147\/OPTH.S342717","volume":"16","author":"MP Paroli","year":"2022","unstructured":"Paroli MP, Del Giudice E, Giovannetti F et al (2022) Management Strategies of Juvenile Idiopathic Arthritis-Associated Chronic Anterior Uveitis: Current Perspectives. Clin Ophthalmol 16:1665\u20131673. https:\/\/doi.org\/10.2147\/OPTH.S342717","journal-title":"Clin Ophthalmol"},{"key":"6759_CR28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/RHU.0000000000001458","volume":"30","author":"M Steiner","year":"2024","unstructured":"Steiner M, del Mar E-O, Thuissard-Vasallo I et al (2024) Choroidal Thickness Is a Biomarker Associated With Response to Treatment in Ankylosing Spondylitis. J Clin Rheumatol 30:131\u2013137. https:\/\/doi.org\/10.1097\/RHU.0000000000001458","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"6759_CR29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12969-020-0417-3","volume":"18","author":"A Baytaro\u011flu","year":"2020","unstructured":"Baytaro\u011flu A, Kadayif\u00e7ilar S, A\u011fin A, Delikta\u015f \u00d6, Demir S, Bilginer Y, Karakaya J, \u00d6zen S, Eldem B (2020) Choroidal vascularity index as a biomarker of systemic inflammation in childhood Polyarteritis Nodosa and adenosine deaminase-2 deficiency. Pediatric Rheumatol 18(1):29. https:\/\/doi.org\/10.1186\/s12969-020-0417-3","journal-title":"Pediatric Rheumatol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-06759-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-025-06759-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-06759-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T09:03:16Z","timestamp":1752138196000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-025-06759-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,1]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["6759"],"URL":"https:\/\/doi.org\/10.1007\/s00417-025-06759-z","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,1]]},"assertion":[{"value":"12 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Gaziantep University Gaziantep, Turkey, and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"During the preparation of this work the authors used QuillBot tool to improve language and readability, with caution. After using this tool\/service, the authors reviewed and edited the content as needed and took full responsibility for the content of the publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted technologies in the writing process"}}]}}